Almis R. Jankus

Array ( [id] => 6851418 [patent_doc_number] => 20030143621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Nuclear matrix proteins' [patent_app_type] => new [patent_app_number] => 10/354480 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14725 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143621.pdf [firstpage_image] =>[orig_patent_app_number] => 10354480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821265 [patent_doc_number] => 20030219426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Therapeutic antiangiogenic compositions and methods' [patent_app_type] => new [patent_app_number] => 10/351284 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16939 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219426.pdf [firstpage_image] =>[orig_patent_app_number] => 10351284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7161131 [patent_doc_number] => 20050084862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Sample preparation for the detection of infectious agents' [patent_app_type] => utility [patent_app_number] => 10/500167 [patent_app_country] => US [patent_app_date] => 2002-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3439 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084862.pdf [firstpage_image] =>[orig_patent_app_number] => 10500167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856138 [patent_doc_number] => 20030129639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'GDU, a novel signalling protein' [patent_app_type] => new [patent_app_number] => 10/323001 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3174 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129639.pdf [firstpage_image] =>[orig_patent_app_number] => 10323001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663675 [patent_doc_number] => 07101985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Methods and compositions in checkpoint signaling' [patent_app_type] => utility [patent_app_number] => 10/300453 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 26 [patent_no_of_words] => 34357 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101985.pdf [firstpage_image] =>[orig_patent_app_number] => 10300453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244767 [patent_doc_number] => 08202688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant' [patent_app_type] => utility [patent_app_number] => 10/300247 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23010 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202688.pdf [firstpage_image] =>[orig_patent_app_number] => 10300247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765589 [patent_doc_number] => 20030099988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Novel Human tumor suppressor' [patent_app_type] => new [patent_app_number] => 10/243815 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17426 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099988.pdf [firstpage_image] =>[orig_patent_app_number] => 10243815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750314 [patent_doc_number] => 20030044834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'GDU, a novel signalling protein' [patent_app_type] => new [patent_app_number] => 10/242332 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3174 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044834.pdf [firstpage_image] =>[orig_patent_app_number] => 10242332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861615 [patent_doc_number] => 20030092623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Bv8 nucleic acids and polypeptides with mitogenic activity' [patent_app_type] => new [patent_app_number] => 10/231411 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 33191 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092623.pdf [firstpage_image] =>[orig_patent_app_number] => 10231411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314252 [patent_doc_number] => 20040033974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Use of genes identified to be involved in tumor development for the development of anti-cancer drugs' [patent_app_type] => new [patent_app_number] => 10/224524 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6219 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033974.pdf [firstpage_image] =>[orig_patent_app_number] => 10224524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7312983 [patent_doc_number] => 20040033495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators' [patent_app_type] => new [patent_app_number] => 10/211462 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 145129 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033495.pdf [firstpage_image] =>[orig_patent_app_number] => 10211462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674281 [patent_doc_number] => 20030059884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/200617 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 616 [patent_figures_cnt] => 616 [patent_no_of_words] => 61099 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059884.pdf [firstpage_image] =>[orig_patent_app_number] => 10200617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783008 [patent_doc_number] => 20030064455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/198766 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 616 [patent_figures_cnt] => 616 [patent_no_of_words] => 61096 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064455.pdf [firstpage_image] =>[orig_patent_app_number] => 10198766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750343 [patent_doc_number] => 20030044863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Invasion complex and methods of targeting' [patent_app_type] => new [patent_app_number] => 10/197725 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5897 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044863.pdf [firstpage_image] =>[orig_patent_app_number] => 10197725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362598 [patent_doc_number] => 20040005313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => ' Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role' [patent_app_type] => new [patent_app_number] => 10/197619 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7044 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005313.pdf [firstpage_image] =>[orig_patent_app_number] => 10197619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846324 [patent_doc_number] => 20030165491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => '22196, a novel human aminopeptidase' [patent_app_type] => new [patent_app_number] => 10/192445 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31371 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165491.pdf [firstpage_image] =>[orig_patent_app_number] => 10192445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846323 [patent_doc_number] => 20030165490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => '22196, a novel human aminopeptidase' [patent_app_type] => new [patent_app_number] => 10/192207 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165490.pdf [firstpage_image] =>[orig_patent_app_number] => 10192207 [rel_patent_id] =>[rel_patent_doc_number] =>)